loadpatents
name:-0.039751052856445
name:-0.022655010223389
name:-0.0061638355255127
Imai; Shin-Ichiro Patent Filings

Imai; Shin-Ichiro

Patent Applications and Registrations

Patent applications and USPTO patent grants for Imai; Shin-Ichiro.The latest application filed is for "production and use of extracellular vesicle-contained enampt".

Company Profile
3.13.16
  • Imai; Shin-Ichiro - St. Louis MO
  • Imai; Shin-ichiro - Saint Louis MO
  • Imai; Shin-ichiro - Somerville MA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Production And Use Of Extracellular Vesicle-contained Enampt
App 20220233443 - Imai; Shin-Ichiro ;   et al.
2022-07-28
Administraton Of Nicotinamide Mononucleotide In The Treatment Of Disease
App 20210346413 - Imai; Shin-ichiro ;   et al.
2021-11-11
Administration of nicotinamide mononucleotide in the treatment of disease
Grant 10,925,888 - Imai , et al. February 23, 2
2021-02-23
Compositions And Methods Of Treatment Using Nicotinamide Mononucleotide
App 20200215087 - Imai; Shin-ichiro ;   et al.
2020-07-09
Administration Of Nicotinamide Mononucleotide In The Treatment Of Disease
App 20190224223 - IMAI; Shin-ichiro ;   et al.
2019-07-25
Administration of nicotinamide mononucleotide in the treatment of disease
Grant 10,258,638 - Imai
2019-04-16
Administration of Nicotinamide Mononucleotide in the Treatment of Disease
App 20180050054 - IMAI; Shin-ichiro
2018-02-22
Administration of nicotinamide mononucleotide in the treatment of disease
Grant 9,844,561 - Imai , et al. December 19, 2
2017-12-19
Administration of Nicotinamide Mononucleotide in the Treatment of Disease
App 20160022712 - IMAI; Shin-ichiro ;   et al.
2016-01-28
Methods of NAD-dependent deacetylation of a lysine residue in a protein
Grant 8,652,797 - Guarente , et al. February 18, 2
2014-02-18
Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein
Grant 8,642,284 - Guarente , et al. February 4, 2
2014-02-04
Sir2 activity
Grant 8,546,074 - Guarente , et al. October 1, 2
2013-10-01
Sir2 Activity
App 20130071378 - Guarente; Leonard ;   et al.
2013-03-21
NAD biosynthesis systems
Grant 8,268,575 - Imai , et al. September 18, 2
2012-09-18
Methods of Affecting Biological Function Through Circadian Clock Feedback Cycle by NAMPT-Mediated NAD+ Biosynthesis
App 20110123510 - Imai; Shin-ichiro ;   et al.
2011-05-26
Processes for regulating blood glucose in a mammal
Grant 7,737,158 - Imai , et al. June 15, 2
2010-06-15
SIR2 Activity
App 20100105036 - Guarente; Leonard ;   et al.
2010-04-29
Nad Biosynthesis Systems
App 20090246803 - Imai; Shin-Ichiro ;   et al.
2009-10-01
SIR2 activity
Grant 7,572,575 - Guarente , et al. August 11, 2
2009-08-11
Methods For Identifying Agents Which Alter Histone Protein Acetylation, Decrease Aging Or Increase Lifespan
App 20090155834 - GUARENTE; LEONARD ;   et al.
2009-06-18
Methods for identifying agents which alter histone protein acetylation
Grant 7,452,664 - Guarente , et al. November 18, 2
2008-11-18
Processes for regulating blood glucose in a mammal and novel polypeptides useful in NAD biosynthesis
App 20070082373 - Imai; Shin-ichiro ;   et al.
2007-04-12
SIR2 activity
App 20060252076 - Guarente; Leonard ;   et al.
2006-11-09
SIR2 activity
App 20040005574 - Guarente, Leonard ;   et al.
2004-01-08
Methods For Identifying Agents Which Alter Histone Protein Acetylation, Decrease Aging, Increase Lifespan
App 20030207325 - Guarente, Leonard P. ;   et al.
2003-11-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed